RPE-mediated Maculopathy
1 clinical trials · Condition
◉ Watch RPE-mediated Maculopathy
| Record | Firm | Date |
|---|---|---|
| Phase 1 Study of C.001 in Retinal Degeneration (NCT07594236) | Cellio Therapeutics Inc | 2026-04-07 |
Track RPE-mediated Maculopathy automatically
Every clearance here is in the API, with alerts when new ones post.